Patient info Open main menu

Posaconazole 300 mg concentrate for solution for infusion – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
300 mg (18 mg/ml)
Contains active substance:

Patient leaflet - Posaconazole 300 mg concentrate for solution for infusion

1. What Posaconazole is and what it is used for

Posaconazole contains a medicine called posaconazole. This belongs to a group of medicines called “antifungals”. Posaconazole is used to prevent and treat many different fungal infections.

Posaconazole works by killing or stopping the growth of some types of fungi that can cause infections.

Posaconazole can be used in adults and children from 2 years of age to treat the following types of fungal infections:

  • infections caused by fungi of the Aspergillus family
  • infections caused by fungi of the Fusarium family that have not improved during

    treatment with amphotericin B or when amphotericin B has had to be stopped; · infections caused by fungi that cause the conditions known as

    “chromoblastomycosis” and “mycetoma” that have not improved during treatment with itraconazole or when itraconazole has had to be stopped;

  • infections caused by a fungus called Coccidioides. that have not improved during

    treatment with one or more of amphotericin B, itraconazole or fluconazole or when these medicines have had to be stopped.

Posaconazole can also be used to prevent fungal infections in adults and children from 2 years of age who are at high-risk of getting a fungal infection, such as: · patients who have a weak immune system due to having chemotherapy for “acute

myelogenous leukaemia” (AML) or “myelodysplastic syndromes” (MDS) · patients having “high-dose immunosuppressive therapy” after “hematopoietic stem

cell transplant” (HSCT).

2. What you need to know before you use Posaconazole

Do not use Posaconazole

  • if you are allergic to posaconazole or any of the other ingredients of this medicine

    (listed in section 6).

  • if you are taking: terfenadine, astemizole, cisapride, pimozide, halofantrine,

    quinidine, any medicines that contain “ergot alkaloids” such as ergotamine or dihydroergotamine, or a “statin” such as simvastatin, atorvastatin or lovastatin. · if you have just started taking venetoclax or your venetoclax dose is being slowly

    increased for treatment of chronic lymphocytic leukaemia (CLL)

Do not use posaconazole if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking posaconazole.

See “Other medicines and posaconazole” below for information on other medicines which may interact with posaconazole.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Posaconazole if you: · have had an allergic reaction to another antifungal medicine such as ketoconazole,

fluconazole, itraconazole or voriconazole.

  • have or have ever had liver problems. You may need to have blood tests while you

    are taking posaconazole.

  • have an abnormal heart rhythm tracing (ECG) that shows a problem called long QTc

    interval

  • have a weakness of the heart muscle or heart failure
  • have a very slow heartbeat
  • have heart rhythm disturbance
  • have any problem with potassium, magnesium or calcium levels in your blood · are taking vincristine, vinblastine and other “vinca alkaloids” (medicines used to

    treat cancer).

  • are taking venetoclax (a medicine used to treat cancer).

You should avoid sun exposure while being treated. It is important to cover sun exposed areas of skin with protective clothing and use sunscreen with a high sun protection factor (SPF), as an increased sensitivity of skin to the sun's UV rays may occur.

If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before using posaconazole.

Children

Posaconazole should not be given to children younger than 2 years of age.

Other medicines and Posaconazole

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Do not take Posaconazole if you are taking any of the following:

  • terfenadine (used to treat allergies)
  • astemizole (used to treat allergies)
  • cisapride (used to treat stomach problems)
  • pimozide (used to treat symptoms of Tourette's and mental illness) · halofantrine (used to treat malaria)
  • quinidine (used to treat abnormal heart rhythms).

Posaconazole can increase the amount of these medicines in the blood which may lead to very serious changes to your heart rhythm.

  • any medicines that contain “ergot alkaloids” such as ergotamine or

    dihydroergotamine used to treat migraines. Posaconazole can increase the amount of these medicines in the blood which may lead to a severe decrease in blood flow to

    your fingers or toes and could cause damage to them.

    • a “statin” such as simvastatin, atorvastatin or lovastatin used to treat high cholesterol.
    • venetoclax when used at the start of the treatment of a type of cancer, chronic lymphocytic leukaemia (CLL)

Do not take posaconazole if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking posaconazole.

Other medicines

Look at the list of medicines given above that must not be taken while you are taking posaconazole. In addition to the medicines named above there are other medicines that carry a risk of rhythm problems that may be greater when they are taken with posaconazole. Please make sure you tell your doctor about all the medicines you are taking (prescribed or non-prescribed).

Certain medicines may increase the risk of side effects of posaconazole by increasing the amount of posaconazole in the blood.

The following medicines may decrease the effectiveness of posaconazole by decreasing the amount of posaconazole in the blood:

  • rifabutin and rifampicin (used to treat certain infections). If you are already taking rifabutin, you will need a blood test and you will need to look out for some possible side effects of rifabutin.
  • phenytoin, carbamazepine, phenobarbital or primidone (used to treat or prevent fits). · efavirenz and fosamprenavir used to treat HIV infection.
  • flucloxacillin (antibiotic used against bacterial infections)

Posaconazole may possibly increase the risk of side effects of some other medicines by increasing the amount of these medicines in the blood. These medicines include: · vincristine, vinblastine and other “vinca alkaloids” (used to treat cancer) · venetoclax (used to treat cancer)

  • ciclosporin (used during or after transplant surgery)
  • tacrolimus and sirolimus (used during or after transplant surgery) · rifabutin (used to treat certain infections)
  • medicines used to treat HIV called protease inhibitors (including lopinavir and atazanavir, which are given with ritonavir)
  • midazolam, triazolam, alprazolam or other “benzodiazepines” (used as sedatives or muscle relaxants)
  • diltiazem, verapamil, nifedipine, nisoldipine or other “calcium channel blockers”

    (used to treat high blood pressure)

  • digoxin (used to treat heart failure)
  • glipizide or other “sulfonylureas” (used to treat high blood sugar) · all-trans retinoic acid (ATRA), also called tretinoin (used to treat certain blood cancers).

If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking posaconazole.

Pregnancy and breast-feeding

Tell your doctor if you are or think you are pregnant before you start to take posaconazole.

Do not use posaconazole if you are pregnant unless you are told to by your doctor. If you are a woman who could become pregnant you should use effective contraception while you are using posaconazole. If you become pregnant while you are using posaconazole, contact your doctor straight away.

Do not breast-feed while using posaconazole. This is because small amounts may pass into breast milk.

Driving and using machines

You may feel dizzy, sleepy, or have blurred vision while taking posaconazole, which may affect your ability to drive or use tools or machines. If this happens, do not drive or use any tools or machines and contact your doctor.

Posaconazole contains sodium

The maximum recommended daily dose of this medicine contains 924 mg sodium (found in table salt).

This is equivalent to 46 % of the adult recommended maximum daily dietary intake for sodium.

Talk to your doctor or pharmacist if you need posaconazole 300 mg concentrate for solution for infusion or more daily for a prolonged period, especially if you have been advised to follow a low salt (sodium) diet.

Posaconazole contains sulfobutyl betadex sodium

This medicinal product contains 6.68 g of sulfobutyl betadex sodium in each vial which is equivalent to 6.68 g/16.7 ml.

3. How to use Posaconazole

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose for adults is 300 mg twice a day on the first day, then 300 mg once a day, thereafter.

The recommended dose for children aged 2 to less than 18 years, is 6 mg/kg to a maximum of 300 mg twice a day on the first day, then 6 mg/kg to a maximum of 300 mg once a day, thereafter.

Posaconazole concentrate for solution for infusion will be diluted to the correct concentration by your pharmacist or nurse.

Posaconazole concentrate for solution for infusion will always be prepared and given to you by a healthcare professional.

You will be given Posaconazole:

  • through a plastic tube placed in your vein (intravenous infusion) · usually over 90 minutes

The length of treatment may depend on the type of infection that you have or the length of time your immune system is not working properly and may be individually adapted for you by your doctor. Do not adapt your dose yourself before consulting your doctor or change your treatment regimen.

If a dose of Posaconazole has been forgotten

As you will be given this medicine under close medical supervision, it is unlikely that a dose would be missed. However, tell your doctor or pharmacist if you think that a dose has been forgotten.

When Posaconazole treatment is stopped by your doctor you should not experience any effects.

UK (Aspiro) Posaconazole 300 mg Leaflet

The following information is intended for healthcare professionals only:

Administration instructions for posaconazole concentrate for solution for infusion · Equilibrate the refrigerated vial of posaconazole to room temperature. · Aseptically transfer 16.7 mL of posaconazole to an intravenous bag (or bottle)

containing a compatible admixture diluent (see below for list of diluents) using the volume ranging from 150 mL to 283 mL depending on the final concentration to be achieved (not less than 1 mg/mL and not greater than 2 mg/mL). · Administer via a central venous line, including a central venous catheter or

peripherally inserted central catheter (PICC) by slow intravenous infusion over approximately 90 minutes. Posaconazole concentrate for solution for infusion should not be given by bolus administration.

  • If a central venous catheter is not available, a single infusion may be administered

    through a peripheral venous catheter with a volume to achieve a dilution of approximately 2 mg/mL. When administered through a peripheral venous catheter, the infusion should be administered over approximately 30 minutes. Note: In clinical studies, multiple peripheral infusions given through the same vein resulted in infusion site reactions (see section 4.8).

  • Posaconazole is for single use.

    The following medicinal products can be infused at the same time through the same intravenous line (or cannula) as posaconazole concentrate for solution for infusion:

    Amikacin sulfate

    Caspofungin

    Ciprofloxacin

    Daptomycin

    Dobutamine hydrochloride

    Famotidine

    Filgrastim

    Gentamicin sulfate

    Hydromorphone hydrochloride

    Levofloxacin

    Lorazepam

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Tell your doctor, pharmacist or nurse straight away if you notice any of the following serious side effects – you may need urgent medical treatment:

  • nausea or vomit (feeling or being sick), diarrhoea,
  • signs of liver problems, these include yellowing of your skin or whites of the eyes,

    unusually dark urine or pale faeces, feeling sick for no reason, stomach problems, loss of appetite or unusual tiredness or weakness, an increase in liver enzymes shown up in blood tests

  • allergic reaction

Other side effects

Tell your doctor, pharmacist or nurse if you notice any of the following side effects:

Common: the following may affect up to 1 in 10 people

  • a change in the salt level in your blood shown in blood tests signs include feeling

    confused or weak

  • abnormal skin sensations, such as numbness, tingling, itching, creeping, pricking, or

    burning

  • swelling, redness, and tenderness along the vein in which posaconazole was given · headache
  • low potassium levels – shown up in blood tests
  • low magnesium levels – shown up in blood tests
  • high blood pressure
  • loss of appetite, stomach pain or upset stomach, passing wind, dry mouth, changes

    in your taste

  • heartburn (a burning sensation in the chest rising up to the throat) · low levels of “neutrophils” a type of white blood cell (neutropenia) – this can make

    you more likely to get infections and be shown up in blood tests · fever

  • feeling weak, dizzy, tired, or sleepy
  • rash
  • itching
  • constipation
  • rectal discomfort

Uncommon: the following may affect up to 1 in 100 people

  • anaemia- signs include headaches, feeling tired or dizzy, being short of breath or

    looking pale and a low level of haemoglobin shown up in blood tests · low level of platelets (thrombocytopenia) shown in blood tests – this may lead to

    bleeding

  • low level of “leukocytes” a type of white blood cell (leukopenia) shown in blood

    tests – this can make you more likely to get infections

  • high level of “eosinophils” a type of white blood cell (eosinophilia) – this can

    happen if you have inflammation

  • inflammation of the blood vessels
  • heart rhythm problems
  • fits (convulsions)
  • nerve damage (neuropathy)
  • abnormal heart rhythm – shown up on a heart trace (ECG), palpitations, slow or fast

    heartbeat, high or low blood pressure

  • low blood pressure
  • inflammation of the pancreas (pancreatitis) – this may cause severe stomach pain · oxygen supply to the spleen is interrupted (splenic infarction) - this may cause

    severe stomach pain

  • severe kidney problems – signs include passing more or less urine that is a different

    colour than usual

  • high blood levels of creatinine – shown in blood tests
  • cough, hiccups
  • nose bleeds
  • severe sharp chest pain when breathing in (pleuritic pain)
  • swelling of lymph glands (lymphadenopathy)
  • reduced feeling of sensitivity especially on the skin
  • tremor
  • high or low blood sugar levels
  • blurred vision, sensitivity to light
  • hair loss (alopecia)
  • mouth ulcers
  • shivering, feeling generally unwell
  • pain, back or neck pain, pain in arms or legs
  • water retention (oedema)
  • menstrual problems (abnormal vaginal bleeding)
  • inability to sleep (insomnia)
  • being completely or partially unable to talk
  • swelling of the mouth
  • abnormal dreams, or difficulty sleeping
  • problems with co-ordination or balance
  • mucosal inflammation
  • stuffy nose
  • difficulty breathing
  • chest discomfort
  • feeling bloated
  • mild to severe nausea, vomiting, cramps and diarrhoea, usually caused by a virus,

    stomach pain

  • belching
  • feeling jittery
  • inflammation or pain at injection site

Rare: the following may affect up to 1 in 1,000 people

  • pneumonia – signs include feeling short of breath and producing discoloured

    phlegm

    • high blood pressure in the blood vessels in the lungs (pulmonary hypertension) this can cause serious damage to your lungs and heart
    • blood problems such as unusual blood clotting or prolonged bleeding · severe allergic reactions, including widespread blistering rash and skin peeling · mental problems such as hearing voices or seeing things that are not there · fainting
    • having problems thinking or talking, having jerking movements, especially in your hands that you cannot control
    • stroke – signs include pain, weakness, numbness, or tingling in the limbs · having a blind or dark spot in your field of vision
    • heart failure or heart attack which could lead to the heart stopping beating and death, heart rhythm problems, with sudden death
    • blood clots in your legs (deep vein thrombosis) – signs include intense pain or swelling of the legs
    • blood clots in your lungs (pulmonary embolism) – signs include feeling short of breath or pain while breathing
    • bleeding into your stomach or gut – signs include vomiting blood or passing blood in your stool
    • a blockage in your gut (intestinal obstruction) especially in the “ileum”. The blockage will prevent the contents of your intestine from passing through to the lower bowel – signs include feeling bloated, vomiting, severe constipation, loss of appetite, and cramps
    • “haemolytic uraemic syndrome” when red blood cells breakup (haemolysis) which may happen with or without kidney failure
    • “pancytopenia” low level of all blood cells (red and white blood cells and platelets)

      shown in blood tests

    • large purple discolourations on the skin (thrombotic thrombocytopenic purpura) · swelling of the face or tongue
    • depression
    • double vision
    • breast pain
    • adrenal glands not working properly – this may cause weakness, tiredness, loss of appetite, skin discolouration
    • pituitary gland not working properly – this may cause low blood levels of some hormones that affect the function of the male or female sex organs · hearing problems
    • pseudoaldosteronism, which results in high blood pressure with a low potassium level (shown in blood test)

Not known: frequency cannot be estimated from the available data · some patients have also reported feeling confused after using posaconazole.

  • redness of the skin

Tell your doctor, pharmacist or nurse if you notice any of the side effects listed above.

Reporting of side effects

If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Posaconazole

Keep this medicine out of the sight and reach of children.

Do not use this medicine after expiry date, which is stated on the label after EXP. The expiry date refers to the last day of that month.

Store in a refrigerator at (2 - 8°C).

Once prepared, the product should be used immediately. If not used immediately, the solution can be stored up to 24 hours at 2°C-8°C (in a refrigerator). This medicine is for single use only and any unused solution should be discarded.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Posaconazole contains

The active substance is posaconazole.

Each vial contains 300 mg of posaconazole.

The other ingredients are: Sulfobutyl betadex sodium, disodium edetate, sodium hydroxide [for pH adjustment], hydrochloric acid [for pH adjustment] & water for injection

What Posaconazole looks like and contents of the pack

Posaconazole concentrate for solution for infusion is a clear colourless to yellow colour solution. Variations of colour within this range do not affect the quality of the product.

This medicine is available in a single use glass vial closed with bromobutyl rubber stopper and aluminium seal.

Marketing Authorisation Holder and Manufacturer

Amarox Limited

Congress House, 14 Lyon Road

Harrow, HA1 2EN

United Kingdom

This leaflet was last revised in 09/2026.

2xxxxxx

Any products not listed in the table above should not be coadministered with posaconazole through the same intravenous line (or cannula).

The infusion solution should be inspected visually for particulate matter prior to administration. The solution of posaconazole ranges from colourless to yellow. Variations of colour within this range do not affect the quality of the product.

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Posaconazole must not be diluted with:

This medicinal product must not be mixed with other medicinal products except those mentioned below:

5 % dextrose in water

0.9 % sodium chloride

0.45 % sodium chloride

5 % dextrose and 0.45 % sodium chloride

5 % dextrose and 0.9 % sodium chloride

5 % dextrose and 20 mEq Kcl

Morphine sulphate

Norepinephrine bitartrate

Potassium chloride

Vancomycin hydrochloride

Meropenem

Micafungin

Lactated Ringer's solution

5 % glucose with Lactated Ringer's solution

4.2 % sodium bicarbonate

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 49445/0272

Last revision stated in the text: September 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Posaconazole 300 mg concentrate for solution for infusion

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Posaconazole
Strength 300 mg (18 mg/ml)
Pharmaceutical form Solution for infusion
A clear colorless to yellow colour solution.
How is it taken Intravenous
Excipients Sulfobutyl betadex sodium, Disodium Edetate, Sodium hydroxide [for pH adjustment], Hydrochloric acid [for pH adjustment], Water for injection
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years
After dilution: 24 hours at 2 - 8°C
From a microbiological point of view, once admixed, the product should be used immediately. If not used immediately, the solution can be stored up to 24 hours refrigerated 2°C-8°C. This medicinal product is for single use only.
Storage Store in a refrigerator at (2 - 8°C).
For storage conditions after dilution of the medicinal product, see section 6.3.
Drug group (ATC) Antimycotics for systemic use, triazole derivatives
  1. J Antiinfectives for systemic use
    1. J02 Antimycotics for systemic use
      1. J02A Antimycotics for systemic use
        1. J02AC Triazole derivatives, systemic antimycotics
          1. J02AC04 posaconazole
Marketing authorisation PL 49445/0272 (first authorised 16 April 2026)
Marketing authorisation holder Amarox Limited
Codes BNF 05020100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.